MedPath

PEGLYTE POWDER

PEGLYTE POWDER

Approved
DIN Number

00777838

Drug Class

Human

Market Date

Dec 31, 1988

Company
HC

pendopharm division of pharmascience inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00777838
AIG Number0516978006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A06AD10 MINERAL SALTS IN COMBINATION
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

MACROGOLActive
Strength: 238.18 G / BOTTLE
Monograph: MACROGOL
POTASSIUM CHLORIDEActive
Strength: 3.05 G / BOTTLE
Monograph: POTASSIUM CHLORIDE
SODIUM BICARBONATEActive
Strength: 6.76 G / BOTTLE
Monograph: SODIUM BICARBONATE
SODIUM CHLORIDEActive
Strength: 5.85 G / BOTTLE
Monograph: SODIUM CHLORIDE
SODIUM SULFATEActive
Strength: 22.96 G / BOTTLE
Monograph: SODIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.